Aigen Investment Management’s DexCom DXCM Stock Holding History

Aigen Investment Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-20,670	Closed	-$1.39M	–	688
2025 Q3	$1.39M	Buy	+20,670	New	+$1.64M	0.22%	132
2025 Q1	–	Sell	-3,989	Closed	-$310K	–	819
2024 Q4	$310K	Sell	3,989 -1,222	-23%	-$90.5K	0.05%	470
2024 Q3	$349K	Buy	+5,211	New	+$428K	0.07%	422
2023 Q4	–	Sell	-12,073	Closed	-$1.13M	–	862
2023 Q3	$1.13M	Buy	+12,073	New	+$1.36M	0.21%	134
2022 Q3	–	Sell	-60,761	Closed	-$4.53M	–	627
2022 Q2	$4.53M	Buy	+60,761	New	+$5.55M	0.76%	22
2022 Q1	–	Sell	-3,216	Closed	-$438K	–	687
2021 Q4	$438K	Buy	+3,216	New	+$462K	0.03%	674
2021 Q1	–	Sell	-17,804	Closed	-$1.65M	–	681
2020 Q4	$1.65M	Buy	17,804 +4,572	+35%	+$408K	0.21%	114
2020 Q3	$1.36M	Sell	13,232 -21,956	-62%	-$2.29M	0.17%	182
2020 Q2	$3.57M	Buy	35,188 +2,952	+9%	+$264K	0.46%	24
2020 Q1	$2.17M	Buy	32,236 +4,876	+18%	+$303K	0.29%	79
2019 Q4	$1.5M	Buy	+27,360	New	+$1.3M	0.25%	104

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Aigen Investment Management's DXCM Position: Q4 2025 in Review

Aigen Investment Management sold out of DexCom (DXCM) in Q4 2025, closing a stake of 20,670 shares — an estimated $1.39M sold.

Aigen Investment Management first reported a position in DXCM in Q4 2019 and held it in 11 quarters. The position peaked at $4.53M in Q2 2022. 922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

Aigen Investment Management reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
Aigen Investment Management sold 20,670 DexCom shares in Q4 2025, an estimated $1.39M.
Aigen Investment Management first reported a position in DexCom in Q4 2019 and held it in 11 quarters.
Aigen Investment Management's DexCom position peaked at $4.53M in Q2 2022.
922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Aigen Investment Management's 13F filing for Q4 2025, filed 13 Feb 2026.